Nasséra Abermil

1.8k total citations · 1 hit paper
15 papers, 950 citations indexed

About

Nasséra Abermil is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Nasséra Abermil has authored 15 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Nasséra Abermil's work include Adrenal and Paraganglionic Tumors (5 papers), Hormonal Regulation and Hypertension (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Nasséra Abermil is often cited by papers focused on Adrenal and Paraganglionic Tumors (5 papers), Hormonal Regulation and Hypertension (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Nasséra Abermil collaborates with scholars based in France, United States and French Polynesia. Nasséra Abermil's co-authors include Nelly Burnichon, Anne‐Paule Gimenez‐Roqueplo, Alexandre Buffet, Judith Favier, Jérôme Bertherat, Laurence Amar, Céline Loriot, Éric Letouzé, Chris Ottolenghi and Aurélien de Reyniès and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Cancer Cell.

In The Last Decade

Nasséra Abermil

15 papers receiving 934 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

2013 551 citations Éric Letouzé, Cosimo Martinelli et al. Cancer Cell profile →

Peers

Countries citing papers authored by Nasséra Abermil

Since Specialization

Citations

This map shows the geographic impact of Nasséra Abermil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasséra Abermil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasséra Abermil more than expected).

Fields of papers citing papers by Nasséra Abermil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasséra Abermil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasséra Abermil. The network helps show where Nasséra Abermil may publish in the future.

Co-authorship network of co-authors of Nasséra Abermil

This figure shows the co-authorship network connecting the top 25 collaborators of Nasséra Abermil. A scholar is included among the top collaborators of Nasséra Abermil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasséra Abermil. Nasséra Abermil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia 2022 ·Haematologica ·Élise Sourdeau, Ludovic Suner, (unknown), Alexis Genthon, Frédéric Féger, (unknown), Nasséra Abermil, (unknown), Chrystèle Bilhou‐Nabera, Hélène Guermouche, Fabrizia Favale, Simona Lapusan, (unknown), (unknown), Mohamad Mohty, Ollivier Legrand, François Delhommeau, Pierre Hirsch	2
2	Oncogenic Integration of Nucleotide Metabolism via Fatty Acid Synthase in Non-Hodgkin Lymphoma 2021 ·Frontiers in Oncology ·Dashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, Frederick Lansigan, William B. Kinlaw, Nirupa R. Matthan, (unknown), Frank Passero, (unknown), Kevin A. David, Gregory G. Dolnikowski, Xiaoyang Su, Ying Chen, (unknown), Rohan Varshney, Baek Kim, Sandeep S. Davé, Michael C. Rudolph, Andrew M. Evens	11
3	Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia 2017 ·Haematologica ·Pierre Hirsch, Ruoping Tang, Nasséra Abermil, Pascale Flandrin‐Gresta, Hannah Moatti, Fabrizia Favale, Ludovic Suner, (unknown), Christophe Marzac, Fanny Fava, Anne‐Claire Mamez, Simona Lapusan, Françoise Isnard, Mohamad Mohty, Ollivier Legrand, Luc Douay, Chrystèle Bilhou‐Nabera, François Delhommeau	38
4	Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma 2016 ·Cancer Research ·Dashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, Frank Passero, (unknown), (unknown), Athena Kritharis, Irawati Kandela, Lynn Hlatky, Michail V. Sitkovsky, Andrew P. Mazar, Ronald B. Gartenhaus, Andrew M. Evens	34
5	The Proteasome Inhibitor, Ixazomib, Combined with Novel Drug Combinations in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Identification of Key Genes and Signaling Pathways Via a Novel Systems Biology Approach 2015 ·Blood ·Frank Passero, Dashnamoorthy Ravi, Afshin Beheshti, Lynn Hlatky, Nasséra Abermil, (unknown), (unknown), Andrew M. Evens	2
6	Lipid Addiction of Diffuse Large B-Cell Lymphoma (DLBCL): Fatty Acid Synthase (FASN) and PI3K Dependent Cell Death Identifies a Novel Therapeutic Paradigm 2015 ·Blood ·Dashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, Frederick Lansigan, William B. Kinlaw, R B Gartenhaus, Graham B. Jones, Lynn Hlatky, Andrew M. Evens	3
7	The Lipid Addiction of Diffuse Large B-Cell Lymphoma (DLBCL) and Potential Treatment Strategies with Novel Fatty Acid Synthase (FASN) Small Molecule Inhibitors 2014 ·Blood ·Dashnamoorthy Ravi, Nasséra Abermil, (unknown), (unknown), Frederick Lansigan, William B. Kinlaw, Ronald B. Gartenhaus, Graham B. Jones, Lynn Hlatky, Andrew M. Evens	7
8	SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma breakdown → 2013 ·Cancer Cell ·Éric Letouzé, Cosimo Martinelli, Céline Loriot, Nelly Burnichon, Nasséra Abermil, Chris Ottolenghi, Maxime Janin, Mélanie Menara, (unknown), Paule Bénit, Alexandre Buffet, Charles Marcaillou, Jérôme Bertherat, Laurence Amar, Pierre Rustin, Aurélien de Reyniès, Anne‐Paule Gimenez‐Roqueplo, Judith Favier	551
9	Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma 2012 ·Human Molecular Genetics ·Nelly Burnichon, Alexandre Buffet, Béatrice Parfait, Éric Letouzé, Ingrid Laurendeau, Céline Loriot, Éric Pasmant, Nasséra Abermil, L. Valeyrie‐Allanore, Jérôme Bertherat, Laurence Amar, Dominique Vidaud, Judith Favier, Anne‐Paule Gimenez‐Roqueplo	106
10	The genetics of paragangliomas 2012 ·European Annals of Otorhinolaryngology Head and Neck Diseases ·Nelly Burnichon, Nasséra Abermil, Alexandre Buffet, Judith Favier, Anne‐Paule Gimenez‐Roqueplo	28
11	TMEM127Screening in a Large Cohort of Patients with Pheochromocytoma and/or Paraganglioma 2012 ·The Journal of Clinical Endocrinology & Metabolism ·Nasséra Abermil, Marine Guillaud-Bataille, Nelly Burnichon, Annabelle Vénisse, Philippe Manivet, Laurence Guignat, D. Drui, (unknown), (unknown), Hélène Affres, Pierre‐François Plouin, Jérôme Bertherat, Xavier Jeunemaı̂tre, Anne‐Paule Gimenez‐Roqueplo	42
12	A Decade (2001-2010) of Genetic Testing for Pheochromocytoma and Paraganglioma 2012 ·Hormone and Metabolic Research ·Alexandre Buffet, Annabelle Vénisse, Valérie Nau, (unknown), Valérie Boccio, (unknown), (unknown), C. Travers, Christophe Simian, Nelly Burnichon, Nasséra Abermil, Judith Favier, Xavier Jeunemaı̂tre, Anne‐Paule Gimenez‐Roqueplo	87
13	Degradation of fungal DNA in formalin-fixed paraffin-embedded sinus fungal balls hampers reliable sequence-based identification of fungi 2010 ·Medical Mycology ·Odile Cabaret, (unknown), Nasséra Abermil, Issam Abd Alsamad, Françoise Botterel, Jean‐Marc Costa, Jean‐François Papon, Stéphane Bretagne	25
14	In vivo depletion of T lymphocyte-specific transcription factors by RNA interference 2010 ·Cell Cycle ·Antoine Tesnière, Nasséra Abermil, F. Schlemmer, Noëlia Casares, Oliver Kepp, Marie O. Péquignot, Mickaël Michaud, Isabelle Martins, Laura Senovilla, Laurence Zitvogel, Guido Kroemer	5
15	Gestational age‐related reference values for amniotic fluid organic acids 2009 ·Prenatal Diagnosis ·Chris Ottolenghi, Nasséra Abermil, Alain Lescoat, Joëlle Aupetit, (unknown), (unknown), Daniel Ricquier, Bernadette Chadefaux-Vekemans, Daniel Rabier	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact